PHAGESELECT
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jul 2024)
What this means for you
This application is over — abandoned 15 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97620822
- Mark type
- Design + words
- Filed
- 05 Oct 2022
- Published for opposition
- 18 Apr 2023
- Abandoned
- 15 Jul 2024
- Attorney of record
- Leesa N. Weiss
Goods and services
- Class 001 — Chemicals: diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising diagnostic reagents for testing bacteria sensitivity, except for medical or veterinary use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the fields of farming and food preparation; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the industrial and food preparation fields
- Class 005 — Pharmaceuticals: human, animal, plant and microorganism biological preparations for disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprising medical diagnostic reagents for testing bacteria sensitivity
- Class 009 — Scientific and electric apparatus: Computer software system comprised of downloadable computer software for identifying precision therapy for treatment of bacterial infections
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals in the nature of bacteriophage therapeutics for others
- Class 042 — Scientific and technological services: new product research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals; medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom biochemical assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; new product research and development of vaccines and therapeutics; providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto; scientific and medical research, in particular, design and development of diagnostic assays; medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto
- Class 044 — Medical, beauty and agricultural services: medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; medical consulting services in the field of medical diagnostic and prognostic testing; medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes; medical analysis services relating to the diagnosis and treatment of a person; medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
Owner
- Adaptive Phage Therapeutics, Inc., Gaithersburg, MD, US
- Adaptive Phage Therapeutics, Inc., Gaithersburg, MD, US
Prosecution history
- 15 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2023 — SOU EXTENSION 1 GRANTED
- 06 Dec 2023 — SOU EXTENSION 1 FILED
- 06 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Apr 2023 — PUBLISHED FOR OPPOSITION
- 04 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Apr 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Apr 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Apr 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED